Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/21420
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVrtala, S.en
dc.contributor.authorHirtenlehner, K.en
dc.contributor.authorSusani, M.en
dc.contributor.authorAkdis, M.en
dc.contributor.authorKussebi, F.en
dc.contributor.authorAkdis, C. A.en
dc.contributor.authorBlaser, K.en
dc.contributor.authorHufnagl, P.en
dc.contributor.authorBinder, B. R.en
dc.contributor.authorPolitou, A.en
dc.contributor.authorPastore, A.en
dc.contributor.authorVangelista, L.en
dc.contributor.authorSperr, W. R.en
dc.contributor.authorSemper, H.en
dc.contributor.authorValent, P.en
dc.contributor.authorEbner, C.en
dc.contributor.authorKraft, D.en
dc.contributor.authorValenta, R.en
dc.date.accessioned2015-11-24T19:14:56Z-
dc.date.available2015-11-24T19:14:56Z-
dc.identifier.issn0892-6638-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/21420-
dc.rightsDefault Licence-
dc.subjectAllergens/genetics/*immunologyen
dc.subjectAntigens, Planten
dc.subjectCell Divisionen
dc.subjectCells, Cultureden
dc.subjectCytokines/metabolismen
dc.subjectEpitopes, B-Lymphocyte/immunologyen
dc.subjectEpitopes, T-Lymphocyte/immunologyen
dc.subjectGenetic Engineeringen
dc.subjectHumansen
dc.subjectImmunoglobulin E/immunologyen
dc.subjectImmunoglobulin G/immunologyen
dc.subjectPlant Proteins/genetics/*immunologyen
dc.subjectRecombinant Proteins/genetics/immunologyen
dc.subjectT-Lymphocytes/cytology/*immunologyen
dc.subjectTh1 Cells/immunologyen
dc.titleGenetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1en
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1096/fj.00-0767fje-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/11511511-
heal.identifier.secondaryhttp://www.fasebj.org/content/early/2001/09/02/fj.00-0767fje.full.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2001-
heal.abstractAn estimated 100 million individuals suffer from birch pollen allergy. Specific immunotherapy, the only curative allergy treatment, can cause life-threatening anaphylactic side effects. Here, we report the genetic engineering of a recombinant trimer consisting of three covalently linked copies of the major birch pollen allergen, Bet v 1. The trimer exhibited profoundly reduced allergenic activity but contained similar secondary structures such as Bet v 1 wild type, Bet v 1-specific B cell and T-cell epitopes, and induced Th1 cytokine release. As immunogen, rBet v 1 trimer induced IgG antibodies, which blocked patients' IgE binding to Bet v 1 and related allergens. Thus, rBet v 1 trimer represents a novel hypoallergenic vaccine prototype for treatment of one of the most frequent allergy forms.en
heal.journalNameFaseb Journalen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Vrtala-2001-Genetic engineering.pdf1.18 MBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons